Mutagenetix > Incidental Mutation

Incidental Mutation 'R8815:Lpcat2'

672676

Institutional Source

Beutler Lab

Gene Symbol

Lpcat2

Ensembl Gene

ENSMUSG00000033192

Gene Name

lysophosphatidylcholine acyltransferase 2

Synonyms

LPCAT2, Aytl1, Aytl1a, lysoPAFAT/LPCAT2

MMRRC Submission

068650-MU

Accession Numbers

Essential gene?

Probably non essential (E-score: 0.100) question?

Stock #

R8815 (G1)

Quality Score

225.009

Status

Validated

Chromosome

Chromosomal Location

93581967-93645907 bp(+) (GRCm39)

Type of Mutation

missense

DNA Base Change (assembly)

A to G at 93640979 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Isoleucine to Valine at position 475 (I475V)

Ref Sequence

ENSEMBL: ENSMUSP00000049252 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000046290] [ENSMUST00000209265] [ENSMUST00000210099]

AlphaFold

Q8BYI6

Predicted Effect

possibly damaging
Transcript: ENSMUST00000046290
AA Change: I475V

PolyPhen 2 Score 0.484 (Sensitivity: 0.89; Specificity: 0.90)

SMART Domains

Protein: ENSMUSP00000049252
Gene: ENSMUSG00000033192
AA Change: I475V

Domain	Start	End	E-Value	Type
low complexity region	5	12	N/A	INTRINSIC
low complexity region	35	45	N/A	INTRINSIC
transmembrane domain	59	81	N/A	INTRINSIC
PlsC	140	251	2.78e-22	SMART
Blast:PlsC	284	326	3e-19	BLAST
EFh	395	423	4.49e-4	SMART
EFh	432	460	6.11e-6	SMART

Predicted Effect

probably benign
Transcript: ENSMUST00000209265

Predicted Effect

probably benign
Transcript: ENSMUST00000210099
AA Change: I435V

PolyPhen 2 Score 0.267 (Sensitivity: 0.91; Specificity: 0.88)

Meta Mutation Damage Score

0.1411

Coding Region Coverage

1x: 100.0%
3x: 99.9%
10x: 99.8%
20x: 99.3%

Validation Efficiency

99% (70/71)

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the lysophospholipid acyltransferase family. The encoded enzyme may function in two ways: to catalyze the biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from 1-O-alkyl-sn-glycero-3-phosphocholine, and to catalyze the synthesis of glycerophospholipid precursors from arachidonyl-CoA and lysophosphatidylcholine. The encoded protein may function in membrane biogenesis and production of platelet-activating factor in inflammatory cells. The enzyme may localize to the endoplasmic reticulum and the Golgi. [provided by RefSeq, Feb 2009]

Allele List at MGI

Other mutations in this stock

Total: 74 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
1700066M21Rik	A	T	1: 57,421,943 (GRCm39)	Q106H	probably damaging	Het
Acad9	T	C	3: 36,139,590 (GRCm39)	C397R	probably damaging	Het
Ankfn1	T	G	11: 89,282,602 (GRCm39)	R348S	probably damaging	Het
Ankrd61	A	G	5: 143,831,336 (GRCm39)	C28R	probably benign	Het
Ano5	C	T	7: 51,194,548 (GRCm39)	R94*	probably null	Het
Apela	A	T	8: 65,489,590 (GRCm39)	F10I	unknown	Het
Arhgap31	T	C	16: 38,429,790 (GRCm39)	S362G	probably benign	Het
Arhgef18	C	A	8: 3,430,410 (GRCm39)	H94Q	probably benign	Het
Astn2	A	T	4: 65,830,834 (GRCm39)	L585Q	possibly damaging	Het
Atf3	G	T	1: 190,909,564 (GRCm39)	A35D	probably benign	Het
Atp10b	A	T	11: 43,093,978 (GRCm39)	R507S	possibly damaging	Het
Brip1	A	C	11: 86,080,598 (GRCm39)	V156G	probably benign	Het
Ccdc27	T	A	4: 154,111,205 (GRCm39)	M636L	probably benign	Het
Ceacam5	T	A	7: 17,493,285 (GRCm39)	N769K	possibly damaging	Het
Cklf	C	T	8: 104,977,560 (GRCm39)		probably benign	Het
Cpeb4	G	A	11: 31,870,546 (GRCm39)	V474M	probably damaging	Het
Dip2c	T	A	13: 9,673,834 (GRCm39)	C1091*	probably null	Het
Eef1akmt4	T	A	16: 20,437,288 (GRCm39)	I210N	possibly damaging	Het
Fbxo38	A	T	18: 62,666,587 (GRCm39)	H195Q	probably damaging	Het
Fbxw14	G	A	9: 109,105,305 (GRCm39)	R287*	probably null	Het
Fes	A	G	7: 80,033,619 (GRCm39)	S211P	possibly damaging	Het
Fry	G	T	5: 150,317,603 (GRCm39)	R861L	possibly damaging	Het
Galnt12	A	G	4: 47,113,908 (GRCm39)		probably benign	Het
Gm14226	G	A	2: 154,866,538 (GRCm39)	W165*	probably null	Het
Gm40460	GCAGCAGCTGGACTGGCAGCAGCAGGGCTTACAGCAGCTGGACTGGCAGCAGCAGGGCTTACAGCAGCTGGACTGGCAGCAGCAGGGCTTACAGCAGCTGGACTGGCAGCAG	GCAGCAGCTGGACTGGCAGCAGCAGGGCTTACAGCAGCTGGACTGGCAGCAGCAGGGCTTACAGCAGCTGGACTGGCAGCAG	7: 141,794,171 (GRCm39)		probably benign	Het
Gm40460	CACAGCCTCCCTTGCAGCCCCCACAGGAACTACAGCCTCCCTTGCAGCCCCCACAGGAACTACAGCCTCCCTTGCAGCCCCCACAGGAACTACAGCCTCCCTTGCAGCCCCCACAG	CACAGCCTCCCTTGCAGCCCCCACAGGAACTACAGCCTCCCTTGCAGCCCCCACAGGAACTACAGCCTCCCTTGCAGCCCCCACAG	7: 141,794,554 (GRCm39)		probably benign	Het
Gprc6a	A	G	10: 51,497,079 (GRCm39)	V488A	probably benign	Het
Haus8	A	T	8: 71,705,910 (GRCm39)		probably benign	Het
Helb	A	T	10: 119,948,692 (GRCm39)	C26S	possibly damaging	Het
Icam1	A	T	9: 20,937,862 (GRCm39)	I300F	probably benign	Het
Ip6k1	A	G	9: 107,918,211 (GRCm39)	N181S	probably benign	Het
Itga2b	C	A	11: 102,351,687 (GRCm39)	R546L	possibly damaging	Het
Kif27	A	T	13: 58,476,818 (GRCm39)	Y611N	probably damaging	Het
Lrit2	A	G	14: 36,794,487 (GRCm39)	K517R	probably benign	Het
Lrp1b	A	T	2: 40,555,171 (GRCm39)	I4085N		Het
Lrrc32	T	A	7: 98,148,242 (GRCm39)	S341T	probably damaging	Het
Lrrn2	T	A	1: 132,866,831 (GRCm39)	I632K	possibly damaging	Het
Mettl22	A	G	16: 8,300,178 (GRCm39)	Q194R	probably benign	Het
Mfhas1	T	A	8: 36,057,394 (GRCm39)	V623E	probably damaging	Het
Mitd1	T	C	1: 37,929,315 (GRCm39)	D26G	probably damaging	Het
Myo1a	C	T	10: 127,546,043 (GRCm39)	T222M	probably benign	Het
Naf1	A	G	8: 67,317,333 (GRCm39)	K275R	possibly damaging	Het
Nf1	T	C	11: 79,332,491 (GRCm39)	L765P	probably damaging	Het
Or12k7	G	T	2: 36,958,429 (GRCm39)	M37I	probably benign	Het
Or52a5	A	G	7: 103,427,063 (GRCm39)	L163P	possibly damaging	Het
Or5ac16	T	A	16: 59,022,264 (GRCm39)	H175L	possibly damaging	Het
Or9r3	T	A	10: 129,947,808 (GRCm39)	I284F	probably damaging	Het
Pappa	A	G	4: 65,099,347 (GRCm39)	H622R	probably benign	Het
Pcdhb4	A	T	18: 37,442,055 (GRCm39)	Y455F	probably damaging	Het
Pepd	A	G	7: 34,671,116 (GRCm39)	Y220C	probably damaging	Het
Pias3	T	C	3: 96,607,381 (GRCm39)	I172T	probably damaging	Het
Polq	T	A	16: 36,853,893 (GRCm39)	H415Q	probably damaging	Het
Pp2d1	A	T	17: 53,814,897 (GRCm39)	M609K	probably benign	Het
Ppm1m	G	A	9: 106,076,237 (GRCm39)		probably benign	Het
Prss22	T	A	17: 24,215,662 (GRCm39)	T87S	probably benign	Het
Ptprf	C	A	4: 118,095,125 (GRCm39)	V254L	possibly damaging	Het
Ripply3	A	G	16: 94,136,723 (GRCm39)	E128G	possibly damaging	Het
Rrm2	A	C	12: 24,760,470 (GRCm39)	I185L	possibly damaging	Het
Sbsn	T	A	7: 30,454,227 (GRCm39)		probably benign	Het
Sdc3	T	A	4: 130,546,336 (GRCm39)	S232T	probably benign	Het
Slx4	G	C	16: 3,803,458 (GRCm39)	P1119A	probably benign	Het
Smc5	C	T	19: 23,221,422 (GRCm39)	R369Q	probably damaging	Het
Speer4a3	A	G	5: 26,158,191 (GRCm39)	S54P	probably damaging	Het
Spns1	G	A	7: 125,971,593 (GRCm39)	S319F	possibly damaging	Het
Sptbn4	G	A	7: 27,106,657 (GRCm39)	Q924*	probably null	Het
Srcap	G	C	7: 127,158,037 (GRCm39)	D2638H	unknown	Het
Srsf12	T	C	4: 33,226,045 (GRCm39)	S103P	possibly damaging	Het
Tanc1	A	G	2: 59,621,185 (GRCm39)	T335A	possibly damaging	Het
Them4	C	T	3: 94,231,610 (GRCm39)	T149I	probably damaging	Het
Trpc7	T	C	13: 56,970,312 (GRCm39)	Y424C	possibly damaging	Het
Ttn	C	T	2: 76,628,364 (GRCm39)	D14599N	probably damaging	Het
Ttn	A	T	2: 76,698,244 (GRCm39)	L186H		Het
Usp17lc	T	C	7: 103,067,524 (GRCm39)	F273S	probably benign	Het
Vwa5b2	T	C	16: 20,419,516 (GRCm39)	S620P	probably damaging	Het

Other mutations in Lpcat2

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL00737:Lpcat2	APN	8	93,635,834 (GRCm39)	missense	probably damaging	1.00
IGL00823:Lpcat2	APN	8	93,591,598 (GRCm39)	missense	possibly damaging	0.90
IGL00911:Lpcat2	APN	8	93,617,338 (GRCm39)	missense	probably damaging	0.99
IGL01449:Lpcat2	APN	8	93,597,775 (GRCm39)	missense	possibly damaging	0.69
IGL01951:Lpcat2	APN	8	93,644,675 (GRCm39)	missense	probably damaging	1.00
IGL02041:Lpcat2	APN	8	93,644,809 (GRCm39)	missense	probably benign	0.04
IGL02491:Lpcat2	APN	8	93,600,879 (GRCm39)	missense	probably damaging	1.00
IGL02957:Lpcat2	APN	8	93,602,212 (GRCm39)	nonsense	probably null
R0960:Lpcat2	UTSW	8	93,596,338 (GRCm39)	missense	probably benign
R1236:Lpcat2	UTSW	8	93,613,197 (GRCm39)	missense	probably damaging	1.00
R1422:Lpcat2	UTSW	8	93,606,045 (GRCm39)	missense	probably damaging	1.00
R1677:Lpcat2	UTSW	8	93,591,560 (GRCm39)	missense	probably benign	0.08
R2048:Lpcat2	UTSW	8	93,596,471 (GRCm39)	missense	possibly damaging	0.94
R3712:Lpcat2	UTSW	8	93,644,798 (GRCm39)	missense	possibly damaging	0.70
R3919:Lpcat2	UTSW	8	93,640,902 (GRCm39)	missense	probably damaging	0.99
R3951:Lpcat2	UTSW	8	93,591,531 (GRCm39)	missense	probably benign
R4357:Lpcat2	UTSW	8	93,599,734 (GRCm39)	missense	probably benign	0.25
R4358:Lpcat2	UTSW	8	93,599,734 (GRCm39)	missense	probably benign	0.25
R4359:Lpcat2	UTSW	8	93,599,734 (GRCm39)	missense	probably benign	0.25
R4401:Lpcat2	UTSW	8	93,599,683 (GRCm39)	missense	possibly damaging	0.61
R4584:Lpcat2	UTSW	8	93,615,999 (GRCm39)	missense	probably damaging	1.00
R5089:Lpcat2	UTSW	8	93,606,071 (GRCm39)	missense	probably damaging	1.00
R5127:Lpcat2	UTSW	8	93,635,819 (GRCm39)	missense	possibly damaging	0.65
R5185:Lpcat2	UTSW	8	93,596,365 (GRCm39)	missense	probably benign	0.04
R6380:Lpcat2	UTSW	8	93,613,209 (GRCm39)	missense	probably benign
R6974:Lpcat2	UTSW	8	93,599,707 (GRCm39)	missense	probably damaging	1.00
R7171:Lpcat2	UTSW	8	93,635,894 (GRCm39)	missense	probably benign	0.00
R7344:Lpcat2	UTSW	8	93,602,195 (GRCm39)	missense	probably damaging	0.98
R7356:Lpcat2	UTSW	8	93,591,611 (GRCm39)	missense	probably benign
R7684:Lpcat2	UTSW	8	93,635,823 (GRCm39)	missense	possibly damaging	0.91
R7834:Lpcat2	UTSW	8	93,644,729 (GRCm39)	missense	possibly damaging	0.63
R7981:Lpcat2	UTSW	8	93,582,182 (GRCm39)	missense	probably damaging	1.00
R7992:Lpcat2	UTSW	8	93,582,186 (GRCm39)	missense	probably damaging	1.00
R8679:Lpcat2	UTSW	8	93,635,864 (GRCm39)	missense	probably damaging	1.00
R8916:Lpcat2	UTSW	8	93,596,316 (GRCm39)	missense	probably benign
R9048:Lpcat2	UTSW	8	93,635,878 (GRCm39)	missense	probably benign	0.00

Predicted Primers

PCR Primer
(F):5'- CACGCCCAAACTGCTGTAAG -3'
(R):5'- GCATGTGAGCCTTCAATAATTAGC -3'

Sequencing Primer
(F):5'- AGGAGTAGCAGATCTATCTCTCTC -3'
(R):5'- TTAGCTATTACTATCACCACCATGAC -3'

Posted On

2021-04-30